Tamavaq™: A Hybrid Quantum–Classical Grover Pipeline for Precision Neoantigen Vaccination in Glioma

Peptide vaccination for primary brain tumors is entering a pragmatic era, enabled by convergent advances in physics-aware artificial intelligence, structure/energetics modeling, and hybrid quantum search. We present Tamavaq™, a closed-loop platform th

Authors

Institutions

Publication Details

Published
2025-10-16
DOI
https://doi.org/10.22541/au.176059300.01649187/v1
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tamavaq™: A Hybrid Quantum–Classical Grover Pipeline for Precision Neoantigen Vaccination in Glioma

Ioannis Grigoriadis
Immunotherapy and Immune Responses
article

Tamavaq™: A Hybrid Quantum–Classical Grover Pipeline for Precision Neoantigen Vaccination in Glioma

Ioannis Grigoriadis
article en

Abstract

Peptide vaccination for primary brain tumors is entering a pragmatic era, enabled by convergent advances in physics-aware artificial intelligence, structure/energetics modeling, and hybrid quantum search. We present Tamavaq™, a closed-loop platform th

Novo Nordisk Foundation (DK)
Openalex Percentile: Top 69%
Immunotherapy and Immune Responses
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Tamavaq™: A Hybrid Quantum–Classical Grover Pipeline for Precision Neoantigen Vaccination in Glioma — Ioannis Grigoriadis · (2025) | TGRS Research Map | TGRS